Bell Rock Capital LLC Gsk PLC Transaction History

Bell Rock Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $11,202 - $16,846	-345 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$40.46 - $43.52 $161 - $174	4 Added 1.17%	345 $14,000
Q2 2019 Jul 31, 2019	BUY	$39.4 - $42.7 $157 - $170	4 Added 1.19%	341 $0
Q1 2019 Apr 08, 2019	SELL	$38.57 - $42.69 $25,571 - $28,303	-663 Reduced 66.3%	337 $14,000
Q1 2017 Dec 05, 2018	BUY	N/A	636 Added 174.73%	1,000 $42,000
Q4 2016 Dec 05, 2018	BUY	N/A	364	364 $14,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.